Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to MR examinations by written consent.
determine the accuracy of MR imaging features in predicting their biological behavior.
METHODS
This study was approved by our institutional review board; requirement for informed patient consent was waived due to the retrospective nature of the study. Preoperative MR examinations of 55 PanNEN patients (29 men, 26 women; mean age of 57.6 years, range 21-83 years) performed between June 2013 and December 2015 were reviewed. Qualitative and quantitative features were compared between tumor grades and stages determined by histopathological analysis.
RESULTS
Ill defined margins were more common in G2-3 and stage Ⅲ-Ⅳ PanNENs than in G1 and low-stage tumors (P < 0.001); this feature had high specificity in the identification of G2-3 and stage Ⅲ-Ⅳ tumors (90.3% and 96%, 95%CI: 73.1-97.5 and 77.7-99.8). The mean apparent diffusion coefficient value was significantly lower in G2-3 and stage Ⅲ-Ⅳ lesions compared to well differentiated and low-stage tumors (1.09 × 10 
INTRODUCTION
The biological behavior of pancreatic neuroendocrine neoplasms (PanNENs) is heterogeneous. The main adverse prognostic factors are the histopathological grade according to the World Health Organization (WHO) 2010 classification, which mainly relies on the proliferative activity [1] , and the stage at diagnosis [2] .
In fact, several studies demonstrated that high tumor grade and advanced tumor-nodes-metastases (TNM) stage are effective predictors of worse clinical out come and shorter survival after surgical resection [3] [4] [5] . Moreover, tumor grade and stage influence the treat ment strategy: surgical resection should always be considered if technically feasible, even in selected cases of metastatic disease; medical therapies are reserved to locally advanced or metastatic tumors in whom upfront surgery cannot be performed [5] . Pretreatment prediction of the biological behavior is therefore very important in determining an efficient treatment strategy for these tumors, especially when unresectable. Nevertheless, even invasive methods, as fineneedle aspiration (FNA), have a limited accuracy in determining the true proliferative activity of PanNENs [6] . Imaging methods could estimate the malignancy of PanNENs in a non invasive way. In fact, previous studies have identified several imaging features that could predict the malignancy of these tumors: beside wellestablished criteria such as infiltration of peri-pancreatic vessels and liver metastases, other features associated with malignancy are large size, irregular margins, and hypoenhancement during the arterial phase [7] [8] [9] [10] .
Moreover, some authors reported that diffusion weighted (DW) imaging, a technique that depicts and quantifies the random motion of water molecules within biological tissues on magnetic resonance (MR) imaging, might have the capability of roughly dis tinguish high grade PanNENs from G1 tumors [11] [12] [13] [14] . Nevertheless, these results are based on small study populations and the diagnostic accuracy of imaging features in predicting the biological behavior of PanNENs is still undefined; moreover, in most previous studies tumor grade was established by FNA rather than histopathological analysis of surgical specimens. We therefore sought to investigate whether and how MR and DW imaging features could be useful in the non-invasive prediction of the biological behavior of PanNENs in a large cohort of patients who underwent surgery. As a consequence, the aims of this study are to describe MR and DW imaging features of PanNENs according to the 2010 WHO grade classification and European Neuroendocrine Society (ENETS) TNM staging system by comparing them to histopathology and to determine the accuracy of MR imaging features in predicting the biological behavior of these tumors.
MATERIALS AND METHODS

Patient population
This study was approved by our institutional review board and the requirement for informed patient consent was waived due to the retrospective nature of the study.
A search of our histopathology and radiology records for the period June 2013December 2015 revealed 66 patients with resected PanNEN, whose data were considered for inclusion. Inclusion criteria were: his topathological diagnosis of PanNEN after surgical resection and availability of goodquality preoperative MR examinations. Exclusion criteria were: lack of preoperative MR examinations (8 patients) and poor quality MR examinations (3 patients).
Thirty subjects included in this study have been reported in a previous paper [14] ; this prior article dealt with identification and characterization of PanNENs using MR and DW imaging, whereas in this manuscript we report on the correlation between MR and DW imaging findings, tumor grade and biological behavior expressed as the stage at diagnosis.
The final study population comprised 55 patients with a mean age of 57.6 years (range, 2183 years): 29 men (mean age, 58.2 years; range, 3583 years) and 26 women (mean age, 57 years; range, 2177 years).
At histopathological examination of surgical spe cimens, 31 tumors (56.4%) were classified as G1, 20 (36.4%) as G2, and 4 (7.2%) as G3, according to the 2010 WHO classification [1] . Four patients underwent tumor enucleation or middle pancreatectomy without lymphadenectomy, therefore the TNM classification could not be applied; accordingly, the remaining 51 lesions were staged as follows, according to the ENETS TNM classification [15] : stage Ⅰ, 15 lesions (29.4%); stage ⅡA or B, 10 lesions (19.6%); stage ⅢA or B, 19 lesions (37.2%); stage Ⅳ, 7 lesions (13.7%).
MR imaging
All patients signed an informed consent before MR examination. MR imaging was performed in a single institution using a 1.5 T unit (Magnetom Avanto or Aera; Siemens, Erlangen, Germany) using phased array body coils. The patients were asked to fast for 46 h before MR. One hundred mL of pineapple juice were administered 1020 min before MR to prevent signal overlapping from fluidcontaining organs on T2 weighted images. The MR imaging protocol is reported in 
Statistical analysis
For the purpose of statistical analysis, G2 and G3 tumors, as well as stage Ⅲ and stage Ⅳ PanNENs were grouped and considered together. Categorical variables derived from the qualitative analysis were compared between groups using the χ 2 or Fisher's exact tests; the results are presented as numbers of cases and relative frequencies. Continuous G2-3 tumors presented infiltration of peri-pancreatic vessels and liver metastases compared to G1 tumors (25% vs 3.2% and 29.2% vs 0%, P = 0.022 and 0.002, respectively; Figure 2 ). Atrophy of upstream pancreatic parenchyma and dilation of the MPD/CBD were more common among G2-3 tumors and stage Ⅲ-Ⅳ lesions as compared to G1 and stage Ⅰ-Ⅱ tumors, although without significant differences between groups (P = 0.446/0.151, 0.215/0.151, and 0.264/0.275). Most lesions were hypointense on T1 and T1fs weighted images, hyper or isointense on T2w images and hyperintense on fsT2w images. On postcontrast images, most tumors were hyperenhancing on late arterial/pancreatic and portal phase images; most tumors of this series were iso or hyperintense on delayed phase images. No significant differences between tumor grades and stages were found regarding the signal intensity on both unenhanced and post contrast images. Intratumoral fluid areas were more frequently found within G23 PanNENs, albeit without significant differences between tumor grades and stages (P = 0.279 and 0.464). Heterogeneous enhancement was significantly more common among G23 tumors as compared to G1 lesions (P = 0.006); nevertheless, lesions with heterogeneous enhancement were significantly larger than those presenting homogeneous enhancement, independently from tumor grade (39.3 ± 23.5 mm vs 19.8 ± 12.8 mm, P < 0.001).
Details on the results of the qualitative image analysis and the comparison between grades and ENETS TNM stages are reported in Table 4 . The lesions had a mean diameter of 28.7 ± 20.8 mm; G23 tumors were significantly larger than G1 PanNENs (P = 0.017), while no significant differences were found between tumor stages in terms of size (P = 0.080). The mean caliber of the MPD/CBD was 6 ± 2 and 13.4 ± 3.9 mm, respectively; no significant differences between tumor grades were found regarding the extent of MPD/CBD dilation (P = 0.256 and 0.151, respectively), while the MPD/CBD diameter was significantly larger in stage III PanNENs as compared to stage Ⅲ-Ⅳ tumors (P = 0.038 and 0.034, respectively). 
Performances of MR features in predicting the biological behavior
The diagnostic performance of MR imaging parameters in identifying G23 and stage Ⅲ-Ⅳ PanNENs is presented in Table 5 . Among qualitative features, vascular invasion and liver metastases had the highest specificity in identifying G23 tumors (96.7%, 95%CI: 81.599.8). Illdefined margins had high specificity for the identification of G23 and stage Ⅲ-Ⅳ PanNENs variables derived from the quantitative analysis were compared between groups using Student's t test or univariate ANOVA; the results are reported as mean ± SD. Student's t tests and bivariate correlation tests were conducted to assess whether qualitative and quantitative variables were correlated with tumor size. For each significant qualitative feature, the diagnostic performance in the identification of G2-3 and stage Ⅲ-Ⅳ lesions was tested by calculating sensitivity (Se, %), specificity (Sp, %), positive and negative predictive values (PPV/NPV, %). A receiving operator characteristic (ROC) analysis evaluated the diagnostic performance of significant quantitative features, and optimal cutoff values, along with Se, Sp, and PPV/NPV, were thus ascertained. Diagnosis obtained by pathological examination was the external gold standard. The sensitivity and specificity of combinations of the statistically significant MR criteria were also calculated. Statistical analysis was performed with SPSS software version 21.2 (IBM, Chicago, Ill., United States). All P values were considered statistically significant if ≤ 0.05.
RESULTS
Qualitative and quantitative features
Details on the qualitative features are reported in Tables 2 and 3 . Most lesions were located in the body or in the head of the pancreas, without significant differences in terms of location between tumor grades and stages (P = 0.094 and 0.059, respectively). Most tumors presented well defined margins; among tumors presenting illdefined margins, most were found to be G2-3 (13/16; Figure 1 ) or stage Ⅲ-Ⅳ (15/16) at histopathological analysis, with sig nificantly higher frequency when compared to G1 and stage Ⅰ-Ⅱ tumors (81.2% vs 18.8% and 93.8% vs 6.2%, P < 0.001). A significantly higher proportion of Details regarding the diagnostic accuracy of different combinations of MR features in diagnosing G23 tumors are reported in Table 6 . The highest sensitivity and specificity were reached using at least two of these five criteria in combination (79.2%, 95%CI: 57.392.1; and 80.6%, 95%CI: 61.991.9); in particular, the highest specificity values (100%) in diagnosing G23 tumors were reached using a combination of illdefined margins and vascular involvement and/or liver metastases and illdefined margins.
DISCUSSION
PanNENs have a wide variety of biological behavior. Although all PanNENs have a malignant potential, the biologic aggressiveness and metastasizing risk are variable. The 2010 WHO classification categorize PanNENs into three classes based on their mitotic activity, expressed as mitotic rate or Ki67 index: G1, < 2 mitoses/2 mm 2 (10 high power fields, 40× magnification) and/or a Ki67 index ≤ 2%; G2, 220 mitoses/2 mm 2 and/or a Ki67 index between 3%
and 20%, and G3, ≥ 21 mitoses/2 mm 2 and a Ki67 index > 20% [1, 15] . Previous studies demonstrated that Ki67 value is an independent predictor of survival for PanNENs [16] . Strosberg et al [17] reported 5year De Robertis R et al . MR features of pancreatic neuroendocrine neoplasms [18] , the 5year survival rates for the stages Ⅰ, Ⅱ, Ⅲ, and Ⅳ were 75.5%, 72.7%, 29.0%, and notassessable, respectively. Rindi et al [2] reported that the ENETS TNM staging system perfectly allocated patients into four statistically significantly different and equally populated risk groups, with stage Ⅱ hazard ratio (HR) of death equal to 16.23, stage Ⅲ HR of death of 51.81, and stage Ⅳ HR of death of 160, considering stage Ⅰ as the reference. It is still controversial which, between tumor grade and stage, has a greater influence on survival. At this regard, a study conducted by MartinPerez et al [3] reported that patients with surgically resected loco regional disease and high Ki67 index (> 20%) had worse prognosis (17% 5year survival rate) than those with advanced disease but low proliferative index (63% 5year survival rate). These data suggest that Ki67 index have a greater impact on survival than the extent of disease. The treatment of choice for PanNENs is surgical resection, which should always be considered if technically feasible, even in selected cases of metastatic disease [5] ; medical therapies, including chemotherapy, antiangiogenic drugs and peptide receptor radionuclide therapy, are reserved to locally advanced or metastatic tumors in whom upfront surgical resection cannot be De Robertis R et al . MR features of pancreatic neuroendocrine neoplasms 
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performed. Small (< 20 mm) nonhyperfunctioning PanNENs have a low malignant potential, therefore a followup strategy can be adopted in such cases [5] . The treatment strategy of PanNENs, however, differs according to their malignancy. Therefore, the more precise will be the pretreatment prediction of the biological behavior of PanNENs, the more effective will be their treatment. In this setting, besides the well established criteria of malignancy such as the infiltration of peripancreatic vessels and liver metastases, a parameter associated with malignancy is tumor size [7, 8] .
In our series, G23 tumors were significantly larger than G1 PanNENs (36.7 mm vs 22.6 mm, P = 0.022); the optimal size cut-off for the identification of G2-3 tumors was found to be 17.5 mm, a value that yielded a sensitivity of 91.7%. As previously mentioned, a non-operative management has been advocated for nonhyperfunctioning tumors below 20 mm when discovered incidentally [5] ; in the present study, after the exclusion of 8 hyperfunctioning PanNENs from our sample population, a cutoff value of 20 mm provided a sensitivity of 79.2% for the identification of G23 tumors. Illdefined margins are significantly associa ted with aggressive lesions [9] ; in our series, illdefined margins were significantly more common among highgrade and highstage tumors, with a specificity of 90.3 and 96% for the identification of G23 and stage Ⅲ-Ⅳ tumors, respectively. On conventional MR sequences, PanNENs have quite a broad spectrum of appearance. Poorly differentiated PanNENs may lack typical MR features, as hypervascularization during the late arterial/pancreatic phase [9] . Kim et al [9] and Jang et al [11] reported that arterial phase hypointensity was significantly associated with tumors with higher degree of dedifferentiation. We found similar results, as indicated by the higher proportion of G23 and stage Ⅲ-Ⅳ tumors among lesions showing hypointensity on late arterial/pancreatic phase images compared to G1 and stage Ⅰ-Ⅱ tumors (69.2% and 75% vs 30.8% and 25%, respectively), although without significant differences between groups. In the present study, the presence of heterogeneous enhancement was a good predictor of G23 tumors (specificity, 71%); nevertheless, heterogeneous enhancement has been correlated also with tumor size [19] and our results confirms these data: in the present series, PanNENs showing heterogeneous enhancement were significantly larger than homogenous lesions (19.8 mm vs 39.3 mm, P < 0.001), independently from tumor grade. DWI appears to be a promising adjunct for the identification of PanNENs and liver metastases, as reported in previous studies [14, 2022] . An inverse correlation between the ADC value and tumor cellularity has been reported in a variety of neoplasms [23] [24] [25] [26] : a probable explanation is that increased cellularity causes a decrease in extracellular spaces, which results in restriction of water diffusion. According to the WHO classification, tumor grade in PanNENs is directly linked to tumor cellularity: the higher the degree of cellularity, the poorer the differentiation [1] : theoretically, increased tumor cellularity and reduced cytoplasmic volume will restrict the free motion of water molecules, resulting in a decrease in ADC values [27] . /s for the identification of G2-3 tumors and stage Ⅲ-Ⅳ tumors, with sensitivity and specificity values of 70.8/80.7% and 64.5/64%, respectively. In the present series, no correlations were found between ADC values and tumor size (P = 0.236). Our results therefore may suggest a prognostic role for ADC quantification. Our study has some limitations. First, although we recruited patients who met the inclusion criteria, we cannot rule out a selection bias that may have resulted from the retrospective design of this study. Second, manual measurements of ADC values may be poorly reproducible and unreliable for small lesions due the low spatial resolution of DW images. Finally, extracellular accumulation of collagen, glycosaminoglycans and proteoglycans as well as infiltrating leukocytes may cause restriction of water diffusion in PanNENs in addition to high cellularity: some tumors may present intratumoral fibrosis, and even if well differentiated, they can demonstrate low ADC values. These aspects were explained by Wang et al [12] , who found a difference in mean ADCs between welldifferentiated PanNENs and endocrine carcinomas, but a significant inverse correlation between ADC values and the cellularity of PanNENs was only observed after excluding three well differentiated tumors with benign behavior and marked fibrosis. It must be otherwise considered that PanNENs containing fibrosis are uncommon; McCall et al [28] found only 14% lesions with prominent stromal fibrosis in their large PanNEN series. Further studies, possibly involving intravoxel incoherent motion DW imaging, are needed to better understand the relationship between histopathological features of PanNENs and water diffusivity evaluated with MRDWI.
In conclusion, our study demonstrated that MR features of PanNENs vary according to the grade of differentiation and the ENETS TNM stage and can predict the biological behavior of these tumors. In particular, irregular margins and low ADC values are good predictors of less-differentiated PanNENs and tumors with higher biological malignancy. MR features may be helpful, in addiction to tissue sampling, to define the most appropriate treatment strategy for PanNENs.
COMMENTS
Background
Pretreatment prediction of the biological behavior of pancreatic neuroendocrine neoplasms (PanNENs) is crucial to determine an efficient treatment strategy for these tumors, especially when unresectable. Nevertheless, even invasive methods, as fine-needle aspiration (FNA), have a limited accuracy in determining the true proliferative activity of these tumors. Imaging methods could estimate the malignancy of PanNENs in a non-invasive way. Nevertheless, these results are based on small study populations and the diagnostic accuracy of imaging features in predicting the biological behavior of these tumors is still undefined.
Research frontiers
The aims of this study are to describe magnetic resonance (MR) and diffusionweighted imaging features of PanNENs according to the 2010 World Health Organization grade classification and European Neuroendocrine Tumor Society tumor-nodes-metastases (TNM) staging system by comparing them to histopathology and to determine the accuracy of MR imaging features in predicting the biological behavior of these tumors.
Innovations and breakthroughs
One of the major strenghts of our study is that histopathological analysis was based on surgical specimens, while in most previous study FNA was considered as the external gold standard. This study demonstrated that MR imaging features of PanNENs vary according to the grade of differentiation and the European Neuroendocrine Society TNM stage and can predict the biological behavior of these tumors. In particular, besides other well-known features as liver metastases and vascular infiltration, irregular margins and low apparent diffusion coefficient (ADC) values are good predictors of less-differentiated tumors and of those with higher biological malignancy. MR features may be helpful, in addiction to tissue sampling, to define the most appropriate treatment strategy for PanNENs.
Applications
MR features, especially the mean ADC value calculated by the placement of regions of interest within the tumor, may be helpful, in addiction to tissue sampling, to define the most appropriate treatment strategy for PanNENs.
